TY  - GEN
AU  - Ørnbjerg, Lykke M
AU  - Rugbjerg, Kathrine
AU  - Georgiadis, Stylianos
AU  - Rasmussen, Simon H
AU  - Jacobsson, Lennart
AU  - Loft, Anne G
AU  - Iannone, Florenzo
AU  - Fagerli, Karen M
AU  - Vencovsky, Jiri
AU  - Santos, Maria J
AU  - Möller, Burkhard
AU  - Pombo-Suarez, Manuel
AU  - Rotar, Ziga
AU  - Gudbjornsson, Bjorn
AU  - Cefle, Ayse
AU  - Eklund, Kari
AU  - Codreanu, Catalin
AU  - Jones, Gareth
AU  - van der Sande, Marleen
AU  - Wallman, Johan K
AU  - Sebastiani, Marco
AU  - Michelsen, Brigitte
AU  - Závada, Jakub
AU  - Nissen, Michael J
AU  - Sanchez-Piedra, Carlos
AU  - Tomšič, Matija
AU  - Love, Thorvardur J
AU  - Relas, Heikki
AU  - Mogosan, Corina
AU  - Hetland, Merete L
AU  - Østergaard, Mikkel
PY  - 2024
DO  - 10.3899/jrheum.2023-0764
SN  - 0315-162X
UR  - https://hdl.handle.net/20.500.12105/25431
AB  - Objective: To evaluate patient-reported outcomes (PROs) after initiation of tumor necrosis factor inhibitor (TNFi) treatment in European real-world patients with psoriatic arthritis (PsA). Further, to investigate PRO remission rates across treatment...
LA  - eng
PB  - Journal Of Rheumatology Publishing Co
KW  - Epidemiology
KW  - Fatigue
KW  - Pain
KW  - Psoriatic arthritis
KW  - Tumor necrosis factor inhibitors
KW  - Antirheumatic Agents
KW  - Arthritis, Psoriatic
KW  - Biological Products
KW  - Female
KW  - Humans
KW  - Male
KW  - Pain
KW  - Patient Reported Outcome Measures
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor Inhibitors
TI  - Patient-Reported Outcomes (PROs) and PRO Remission Rates in 12,262 Biologic-Naïve Patients With Psoriatic Arthritis Treated With Tumor Necrosis Factor Inhibitors in Routine Care
TY  - research article
ER  -